期刊文献+

曲安奈德染色玻璃体联合高速玻切治疗增殖性糖尿病视网膜病变 被引量:2

Triamcionlone acetonide(TA) and high-speed vitrectomy used for proliferative diabetic retinopathy
原文传递
导出
摘要 目的探讨曲安奈德染色玻璃体联合高速玻璃体切除(玻切)在增殖性糖尿病视网膜病变(PDR)手术中的应用价值。方法选取增殖性糖尿病视网膜病变(PDR)31例31只眼,切除中轴部玻璃体后,注入曲安奈德(TA)混悬液,染色玻璃体,高速玻切切除残留玻璃体后皮质及视网膜前膜。术后随访时重点观察患者视力、眼压、白内障形成、是否有玻璃体残留再次增殖及视网膜复位情况。结果3l例患者术中注入曲安奈德后,残留玻璃体及视网膜前膜均能清晰显示,利用高速玻切可容易切除残留玻璃体及视网膜前膜。术后随访观察3~10个月,31只眼中25只眼视力不同程度提高,11(91.7%)眼视网膜复位。结论PDR玻璃体切除术中,应用TA染色玻璃体,可清晰显示后部残留玻璃体,同时联合应用高速玻切,提高了手术的准确性和安全性,术后并未发现TA相关并发症。 Objective To detect the value of using Triamcionlone acetonide (TA) to chromovitrectomy and high-speed vitrectomy in proliferative diabetic retinopathy (PDR).Methods After cut the axial vitreous of 31 cases ( 31 eyes ) of PDR, TA Was used to dye the vitreous, and then high-speed vitrectomy technique was used to remove the residual vitreous and epiretinal membrane.During the time of fellow-up, visual acuity, intraocular pressure, whether or not had residual vitreous and the rate of retina reattachment were recorded.Resuits The residual vitreous and epiretinal membrane can be easily identified and cut with TA and high-speed vitrectomy technique.The visual acuity of 25 cases was increased and 11 eyes (91.7%) retina reattachment after follow-up period for 3 to 10 months.Conclusions Residual vitreous and epiretinal membrane can be easily identified and cut with TA and high-speed vitrectomy technique.The procedures were performed easily, surely and safely.
出处 《中国实用眼科杂志》 CSCD 北大核心 2009年第9期1007-1008,共2页 Chinese Journal of Practical Ophthalmology
关键词 曲安奈德 染色玻璃体切除术 增殖性糖尿病视网膜病变 Triamcionlone acetonide chromovitrectomy proliferative diabetic retinopathy
  • 相关文献

参考文献4

  • 1Sakamoto T, Miyazaki M, Hisatomi T, etal.Triamcinolone assisted pars plana citrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown.Graefes Arch Clin Exp Ophthalmol, 2002,240: 423-429.
  • 2Peyman GA, Cheema R, Conway MD, etal.Triamcinolone acetonide as an visualization of the vitreous and the posterior hyaloids during pars plana vitrectomy.Retina, 2000,20: 554-555.
  • 3Sonda KH, Sakamoto T, Euaida, etal.Residual vitreous cortex after sutgical posterior vitreous separation visualized by intravitreous Triamcinolone acetonide.Ophthalmology, 2004,111 : 226-230.
  • 4孟浩,惠延年.染色玻璃体切除术[J].国外医学(眼科学分册),2005,29(5):289-292. 被引量:6

二级参考文献28

  • 1Rodrigues EB, Meyer CH, Kroll P. Chromovitrectomy: a new field in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol, 2005,243:291-293.
  • 2Rodrigues EB, Meyer CH. Chromovitrectomy. In: App 7th Vitreoretinal Symposium. Marburg, Germany, 2004:21.
  • 3Hillenkamp J,Saikia P, Gora F, et al. Macular function and morphology after peeling of idiopathic epiretinal membrane with and without the assistance of indocyanine green. Br J Ophthalmol,2005,89: 437-443.
  • 4Sorsby A. Vital staining of the fundus. Trans Ophthal Soc UK,1939;59:727-730.
  • 5Gilford H. Use of fluorescein intravenously as an aid to ophthalmic diagnosis and treatment. Arch Ophthalmol, 1940,24:122-131.
  • 6Kutschera E. Vital staining of the detached retina with retinal breaks. Albrecht Von Graefes Arch Kl in Exp Ophthalmol, 1969,178 : 72-87.
  • 7Melles GRJ, de Waard PW, Pameyer JH, et al. Trypan blue capsule staining to visualize the capsulorhexis in cataract surgery. J Cataract Refract Surg, 1999,25: 7-9.
  • 8Burk SE, Da Mata AP, Snyder ME, et al. Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology, 2000,107: 2010-2014.
  • 9Da Mata AP, Burk SE, Riemann CD, et al. Indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macular hole repair. Ophthalmology, 2001,108:1187-1192.
  • 10Rodrigues EB, Meyer CH, Schmidt JC, et al. Trypan blue stains the epiretinal membrane but not the internal limiting membrane. Br J Ophthalmol, 2003,87:1431-1432.

共引文献5

同被引文献15

  • 1陆寅,孟瑞华,张跃红.醋酸曲安奈德在玻璃体切割手术中的应用[J].眼科研究,2005,23(3):329-329. 被引量:7
  • 2刘武,王景昭.玻璃体内注射曲安奈德的问题与并发症[J].中华眼底病杂志,2005,21(4):267-270. 被引量:39
  • 3Peyman GA,cheema R,Conway MD. Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloids during pars plana vitrectomy[J].Retina-Journal of Retinal and Vitreous Diseases,2000.554-555.
  • 4Albini TA,Abd-EL-Barr MM,Carvounis PE. Long-term retinal toxicity of intravitreal commercially available preserved tramcinolone acetonide(kenalog)in rabbit eye[J].Investigative Ophthalmology & Visual Science,2007,(1):390-395.doi:10.1167/iovs.06-0145.
  • 5Yamakiri K,Sakamoto T,Noda Y. Reduced incidence of intraoperative complications in a muticenter controlled clinical trial of triamcinolone in vitrectomy[J].Ophthalmology,2007.289-296.doi:10.1016/j.ophtha.2006.07.044.
  • 6Eifrig CW,Scott IU,Flynn HW Jr. Endophthalmitis after pars plana vitrectomy:incidence,causative organisms and visual acuity outcomes[J].American Journal of Ophthalmology,2004.799-802.doi:10.1016/j.ajo.2004.06.035.
  • 7Sakamoto T,Enaida H,Kubota T. Incindence of acute endophthalmitis after triamcinolone-assisted par plana vitrectomy[J].American Journal of Ophthalmology,2004.137-138.doi:10.1016/j.ajo.2004.02.072.
  • 8Hida T,Chandler D,Arena JE. Experimental and clinical observation of the intraocular toxicity of commercial corticosteroid preparation[J].American Journal of Ophthalmology,1986.190-195.
  • 9Kivilcim M,Peyman GA,El-Dessouky ES. Retinal toxicity of triamcinolone acetonide in silicone-filled eye[J].Ophthalmic Surgery & Lasers,2000.474-478.
  • 10胡建斌,余雨枫,林伟.玻璃体腔注射曲安奈德治疗糖尿病性视网膜病变黄斑水肿[J].国际眼科杂志,2008,8(2):316-317. 被引量:15

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部